1-4 of 4
Ana Rovira
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer

Sandra Zazo, Paula González-Alonso, Ester Martín-Aparicio, Cristina Chamizo, Melani Luque, Marta Sanz-Álvarez, Pablo Mínguez, Gonzalo Gómez-López, Ion Cristóbal, Cristina Caramés, Jesús García-Foncillas, Pilar Eroles, Ana Lluch, Oriol Arpí, Ana Rovira, Joan Albanell, Juan Madoz-Gúrpide, Federico Rojo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (8): 1696–1707.
https://doi.org/10.1158/1535-7163.MCT-19-1172
Published: 04 August 2020
View articletitled, Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer
Open the PDF for Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer

Aïda Sampera, Francisco Javier Sánchez-Martín, Oriol Arpí, Laura Visa, Mar Iglesias, Sílvia Menéndez, Élisabeth Gaye, Alba Dalmases, Sergi Clavé, Mariona Gelabert-Baldrich, Thomas Tuxen Poulsen, Michael Kragh, Beatriz Bellosillo, Joan Albanell, Ana Rovira, Clara Montagut
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (11): 2135–2145.
https://doi.org/10.1158/1535-7163.MCT-19-0455
Published: 01 November 2019
View articletitled, HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer
Open the PDF for HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer in another window
Includes: Supplementary data
Journal Articles

c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer

Raúl Rincón, Sandra Zazo, Cristina Chamizo, Rebeca Manso, Paula González-Alonso, Ester Martín-Aparicio, Ion Cristóbal, Carmen Cañadas, Rosario Perona, Ana Lluch, Pilar Eroles, Jesús García-Foncillas, Joan Albanell, Ana Rovira, Juan Madoz-Gúrpide, Federico Rojo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (11): 2780–2790.
https://doi.org/10.1158/1535-7163.MCT-15-0920
Published: 01 November 2016
View articletitled, c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer
Open the PDF for c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells

Jordi Codony-Servat, Maria A. Tapia, Marta Bosch, Cristina Oliva, Josep Domingo-Domenech, Begoña Mellado, Mark Rolfe, Jeffrey S. Ross, Pere Gascon, Ana Rovira, Joan Albanell
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 665–675.
https://doi.org/10.1158/1535-7163.MCT-05-0147
Published: 16 March 2006
View articletitled, Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
Open the PDF for Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells in another window